Baseline polymorphisms found in patients infected with non-clade BHIV-1 do not affect outcome to HAART

Baseline polymorphisms found in patients infected with non-clade BHIV-1 do not affect outcome to HAART

Opis bibliograficzny
Główni autorzy:	Frater, A, Galpin, S, Beardall, A, Clarke, JR, Ariyoshi, K, Weber, J, McClure, M
Format:	Journal article
Wydane:	2000

Podobne zapisy

Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients.
od: Frater, A, i wsp.
Wydane: (2001)

Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy.
od: Frater, A, i wsp.
Wydane: (2002)

The impact of HIV-1 subtype on the clinical response on HAART.
od: Frater, J
Wydane: (2002)

Performance of two commercially available sequence-based HIV-1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes.
od: Beddows, S, i wsp.
Wydane: (2003)

HIV-1 resistance genotyping by sequencing produces inconsistent results for mixed viral populations.
od: Frater, A, i wsp.
Wydane: (2000)

Nephrotoxicity of HAART
od: Robert Kalyesubula, i wsp.
Wydane: (2011-01-01)

Simple detection of point mutations associated with HIV-1 drug resistance.
od: Frater, A, i wsp.
Wydane: (2001)

Association between secondary mutations in human immunodeficiency virus type 1 protease and therapeutic outcome.
od: Frater, J, i wsp.
Wydane: (2002)

Neurodegeneration in the HAART era
od: Brew Bruce J
Wydane: (2010-05-01)

HAART and the liver: friend or foe?
od: Pineda JA, i wsp.
Wydane: (2010-03-01)

Chemoprophylaxis and HAART Therapy in Botswana
od: Essex M
Wydane: (2005-12-01)

The R region found in the human foamy virus long terminal repeat is critical for both Gag and Pol protein expression.
od: Russell, R, i wsp.
Wydane: (2001)

Differential susceptibility of retroviruses to nucleoside analogues.
od: Rosenblum, L, i wsp.
Wydane: (2001)

Found footage and magnetization of affection
od: Carlos Adriano
Wydane: (2015-12-01)

Ophthalmic manifestations of human immunodeficiency virus infection: Pre- highly active antiretroviral chemotherapy (HAART) and post- HAART era
od: Sinha Rajesh, i wsp.
Wydane: (2008-01-01)

HIV/HCV coinfection, HAART, and liver-related mortality.
od: Sabin, C, i wsp.
Wydane: (2004)

Mutagenically separated PCR assay for rapid detection of M41L and K70R zidovudine resistance mutations in CRF01_AE (subtype E) human immunodeficiency virus type 1.
od: Myint, L, i wsp.
Wydane: (2002)

Identification of clade-defining single nucleotide polymorphisms for improved rabies virus surveillance
od: Ankeet Kumar, i wsp.
Wydane: (2024-12-01)

Control of viral replication after cessation of HAART
od: Buvé Anne, i wsp.
Wydane: (2011-02-01)

Lipodystrophy syndrome in HIV-infected children on HAART
od: Steve Innes, i wsp.
Wydane: (2009-12-01)

Tolerability of antiretroviral therapy (HAART) in elderly age
od: Celesia B M
Wydane: (2010-05-01)

HAART and ATT in the HIV-positive patient with tuberculosis
od: Zi Z Jhiens, i wsp.
Wydane: (2012-01-01)

Better quality of life with neuropsychological improvement on HAART
od: Hall Colin D, i wsp.
Wydane: (2006-02-01)

Magnitude of cytopenias among HIV‑infected children in Bahir Dar, northwest Ethiopia: a comparison of HAART-naïve and HAART‑experienced children
od: Tsegay YG, i wsp.
Wydane: (2017-02-01)

Assessing the effect of HAART on change in quality of life among HIV-infected women
od: Hu Zheng, i wsp.
Wydane: (2006-03-01)

Anemia and risk factors in HAART naïve and HAART experienced HIV positive persons in south west Ethiopia: a comparative study.
od: Lealem Gedefaw, i wsp.
Wydane: (2013-01-01)

Association of oral candidal carriage, candidal density and CD4 count among normal, HIV patients with HAART and without HAART
od: Shahabe Saquib Abullais, i wsp.
Wydane: (2022-06-01)

Clinical, demographic and laboratory parameters at HAART initiation associated with decreased post-HAART survival in a U.S. military prospective HIV cohort
od: Lifson Alan R, i wsp.
Wydane: (2012-02-01)

Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection
od: Vivek Gopalakrishnan, i wsp.
Wydane: (2020-10-01)

Low Genetic Polymorphism in the Immunogenic Sequences of <i>Rhipicephalus microplus</i> Clade C
od: Ismail Zeb, i wsp.
Wydane: (2022-11-01)

Intensive Care Usage by HIV-Positive Patients in the HAART Era
od: L. Turtle, i wsp.
Wydane: (2011-01-01)

Genetic Markers Associated to Dyslipidemia in HIV-Infected Individuals on HAART
od: Rosmeri K. Lazzaretti, i wsp.
Wydane: (2013-01-01)

Treatment of CMV Retinitis with Intravitreal Ganciclovir in the HAART Era
od: Robert J Campbell, i wsp.
Wydane: (2001-01-01)

HAART, ocular opportunistic infections, ocular malignancies, and uveitis
od: Rujittika Mungmunpuntipantip, i wsp.
Wydane: (2024-01-01)

Causes of hypercalcemia in people living with HIV in the HAART era
od: Arkom Nongnuch, i wsp.
Wydane: (2020-10-01)

Neurologic complications of HIV in the HAART era: where are we?
od: Monica M. Gomes da Silva

HAART (Highly Active Anti-Retroviral Therapy) : An overview
od: Praful Pande, i wsp.
Wydane: (2014-01-01)

Effect of prolonged HAART on oral colonization with <it>Candida </it>and candidiasis
od: Hung Chien-Ching, i wsp.
Wydane: (2006-01-01)

HAART: A Cost-Effective Option for South Africa.
Wydane: (2006-01-01)

Benign Lymphoepithelial Lesion of the Parotid Gland in the Setting of HAART
od: Sergey Arutyunyan MS, i wsp.
Wydane: (2017-03-01)